Health Catalyst (HCAT) Invested Capital (2018 - 2026)

Health Catalyst has reported Invested Capital for 9 years, with the latest figure at $291.5 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 61.63% year-over-year to $291.5 million; the trailing twelve-month figure through Mar 2026 stood at $291.5 million (down 61.63% YoY), and the FY2025 full-year result was $399.0 million, down 46.62% from the prior year.
• Invested Capital for Q1 2026 stood at $291.5 million, down from $399.0 million in the prior quarter.
• The five-year high for Invested Capital was $759.7 million in Q1 2025, with the low at $291.5 million in Q1 2026.
• Historically, Invested Capital has averaged $588.3 million across 5 years, with a median of $610.0 million in 2023.
• Annual changes were most pronounced in 2022 — Invested Capital surged 60.27% — and 2026, when it sank 61.63%.
• Health Catalyst's Invested Capital stood at $425.0 million in 2022, then soared by 39.99% to $595.0 million in 2023, then grew by 25.65% to $747.6 million in 2024, then tumbled by 46.62% to $399.0 million in 2025, then retreated by 26.95% to $291.5 million in 2026.
• The last three Invested Capital figures came in at $291.5 million (Q1 2026), $399.0 million (Q4 2025), and $485.1 million (Q3 2025), per Business Quant data.